Category: Ongoing Compliance

Productwise 3-2-1

Tracey Bischofberger, Matt Howsare and Claire Temple

Productwise 3-2-1, our monthly bite-sized digest of the current key issues in products law.

Representative actions and insurance: some looming traps for product manufacturers

Introduction As reported in our earlier blog, a compromise has recently been reached in respect of the content of a new EU Directive on consumer collective redress (the Directive), with the final directive likely to come into force by the end of the year and member states to transpose it […]

Productwise 3-2-1

Tracey Bischofberger, Matt Howsare and Claire Temple

Introducing Productwise 3-2-1, our monthly bite-sized digest of the current key issues in products law.

General Product Safety Directive Consultation: Commission Checks its Safety Net for Holes

Jamie Humphreys and Edward Turtle

The European Commission is holding a consultation on proposed amendments to the EU’s General Product Safety Directive.

COVID-19: Weekly Life Sciences Digest – International Collaboration and Adjusted Exports/Import Rules

Sarah-Jane Dobson, Edward Turtle and Alicia Johnson-Cole

With COVID-19 heralding unprecedented changes in the sector, our life sciences products experts provide a weekly summary of key international developments to keep you up to date.

Flexibility for our furry friends

Sarah-Jane Dobson and Olivia Flasch

EU regulators have taken steps to address supply chain disruption and increased demand in veterinary medicines caused by the COVID-19 pandemic.

WEBCAST: EU and AI – Navigating the European Approach

Cooley’s international products law team are pleased to announce the fourth event in its webinar series. This webinar will look at the European Union’s approach to Artificial Intelligence including the impact of the European Commission’s White Paper on Artificial Intelligence. The team will be joined by members of Cooley’s Technology […]

UK-specific guidance for the application and management of clinical trials in the context of COVID-19

Sarah-Jane Dobson and Amal Ali

The UK’s MHRA has stated it will be particularly flexible and pragmatic in authorising clinical trials connected to COVID-19, referring to its previous track record of having acted swiftly in past public health crises

WEBCAST: Products & Consumer Rights: Global Hot Topics

Cooley’s international products law team is pleased to announce the third event in its webcast series looking at the latest consumer rights issues product manufacturers, suppliers and other stakeholders are facing in the rapidly changing global environment. This time we will be joined by Wendy Hederman, a partner at leading Irish law […]